Laboratory studies demonstrate increased GH pulse amplitude and IGF1 upregulation without receptor desensitization during short exposure periods

Vitamin A (as all-trans-Retinyl palmitate), Vitamin B1 (as Thiamine HCL), Vitamin B2 (as Riboflavin), Niacin (as Niacinamide), Pantothenic Acid (as Calcium D-pantothenate), Vitamin B6 (as Pyridoxal 5'-phosphate), Vitamin B12 (as Methylcobalamin), Vitamin C (as Ascorbic Acid), Vitamin D3 (as Cholecalciferol) (vegan), Vitamin E (as d-alpha-Tocopheryl acid succinate), Biotin, Folate (as 400 mcg folic acid and 600 mcg calcium L-5-methyltetrahydrofolate), Choline (as Choline Bitartrate), Chromium (as Chromium Citrate), Copper (as Copper Citrate), Iodine (as Potassium Iodide), Magnesium (as Magnesium Citrate), Molybdenum (as Molybdenum Citrate), Selenium (as Selenium Chelate), Zinc (as Zinc Bisglycinate), Iron (as Ferrous Bisglycinate Chelate), CoQ10 (Coenzyme Q10 Ubiquinone -- from microorganism and synthetic sources), NAC (N-Acetyl-L-Cysteine), Acetylcarnitine (as Acetyl-L-Carnitine HCL), Omega-3 (from marine algae, Schizochytrium sp.), DHA (Docosahexaenoic Acid) -- 300 mg, EPA (Eicosapentaenoic Acid) -- 7.5 mg, Schizochytrium sp

Aronne LJ, Horn DB, le Roux CW, SURMOUNT5 Trial Investigators
Clinical trials GLP-1 RAs are an antidiabetic class of drugs, but their effect on the relative reduction in HbA1c compared to placebo was moderate (0.41.2%) in the outcome trials
Early Phase 3 data show it outperforms Novos oral semaglutide, with superior A1C reduction and weight loss (9.2% vs
GLP-1 side effects and safety considerations For those considering GLP-1 therapy for menopause, it is always a good idea to look at the benefits and potential risks